Sam Wilkinson
Bio 1615 tuesday 9am
7/19/16
Scientific Article Summary assignment
(Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage inHumans)
Introduction
The objective of this study was to determine how and why cancer resistance in elephants is so prolific, and the researchers did this by comparing the cellular reactions to DNA damage of elephants, healthy human controls, and cancer-prone patients with Li-Fraumeni syndrome, which is a genetic disorder characterized by a mutated p53 gene that is not able to stop cancer cells from multiplying. The study was designed to examine data from 36 different mammal species to show proof of cancer resistance in species with long lifespans like elephants. African and Asian elephants genome were examined for potential reasons as to why elephants can resist cancer so well. To study each specimen a type of white blood cell called a Peripheral blood lymphocytes, was taken from the elephants, healthy humans acting as controls, and patients with Li-Fraumeni syndrome.
Materials/Methods
Each sample was were exposed to radiation and tested in a lab environment with “in vitro” tests, which in this case means in glass lab containers. Post death data from the San Diego Zoo was also compiled which composed off information about cancer and the 36 mammal species included in the study. This data was then used in a cancer transformation model and the cellular mutation rate was calculated to compare the increase in a cancerous cell mass in a human vs. elephant. More data was also acquired by performing a genomic sequence analysis of publicly available data of the African elephant genome from the Ensemble and NCBI gene database to examine any cancer-related genes and also tumor suppressors like the P53 gene. The African and Asian gene sequences were cloned and resequenced for examination and also a whole genome sequencing was examined on freshly drawn blood (DNA) from an African elephant from the Utah’s Hogel Zoo. With this compiled data, the scientists then compared it across all the 36 included species, and cancer incidence was estimated by the number of animals that had reportedly died of cancer.
Results
From The studies 36 different mammal species, it was concluded that cancer risk did not increase with body size and maximum life span. Among the 644 known elephant deaths from the Elephant Encyclopedia database, the lifetime cancer incidence was 3.11%. The study also concluded that “The risk of cancer depends on both the number of cells in the body and the number of years over which those cells can accumulate mutations; therefore, cancer incidence is plotted as a function of mass × life span”.
From analyzing the the African Elephant genome the scientist discovered that the elephants have 19 copies of the TP53 gene. The human genome contains just 1 copy of the TP53 gene and of the 19 copies that The African Elephant has, 18 of them are unique retrogenes which means they are copies of the original from an RNA transcribed from a DNA gene copied back by reverse transcription. The Asian elephant was also found to contain 15 to 20 copies of the TP53 gene in its DNA. The white blood cells of the lymphatic system, or “lymphocytes” of the elephants were found to undergo TP53 -dependent cell apoptosis ( cell termination) in response to DNA damage, and their fibroblasts ( common cells of connective tissue in animals ) underwent both p53-dependent apoptosis and cell cycle arrest at significantly higher rates compared with human lymphocytes after 18 hours of ionized radiation.
Discussion
This is an exciting study not only for what it discovered, but this is also the first time this type of study has been done on large mammals with long life spans, and the author writes “ this study offers the first supporting evidence based on empirical data that larger animals with longer life spans may develop less cancer, especially elephants”. The TP53 gene is critical in cancer suppression and response to DNA damage through apoptosis and cell cycle arrest and this supports the reasoning that Patients with LFS inherit only 1 functioning TP53 allele and may have a lifetime cancer risk at nearly 100%. Simply put, elephants have more “security guards” available to destroy mutated cells before they ever have a chance to multiply. This is exciting because it could prove vital for cancer treatments in humans and inserting additional copies of TP53 genes in mice adds cancer resistance with accelerated aging and hopefully we can apply this to our species one day.
Conclussions
Compared with other mammal species, elephants showed to have lower-than-expected rates of cancer, and this could potentially be attributed to multiple copies of the TP53 gene. Compared with human cells, elephant cells showed and increase in apoptosis in response to DNA damage.If these findings could be replicated in humans it could represent an evolutionary-based path for understanding how to defeat cancer.
Bibliography
1.The Journal of The American Medical Association, November 3rd 2015, Vol 314
Web Page, http://jama.jamanetwork.com/article.aspx?articleid=2456041





